AIM: To determine the frequency of paediatric hospital admissions associated with drug-related problems (DRPs) at two Australian hospitals. METHODS: The investigator and ward pharmacists prospectively screened eligible patients. A multidisciplinary panel reviewed data and established causality, preventability and clinical significance classifications. RESULTS: Over 22 weeks of data collection, a total of 11,564 patients were admitted, 2933 met eligibility criteria. Of those eligible, 127 [4.3%, 95% confidence interval (CI) 3.6, 5.0] were judged to have hospital admissions associated with DRPs. Direct costs associated with DRPs identified totalled pounds 100,707. Of the 81 cases assessed for preventability, 46.9% were deemed preventable. CONCLUSIONS: This research has provided information on the nature and characteristics of paediatric DRPs associated with hospital admissions.
AIM: To determine the frequency of paediatric hospital admissions associated with drug-related problems (DRPs) at two Australian hospitals. METHODS: The investigator and ward pharmacists prospectively screened eligible patients. A multidisciplinary panel reviewed data and established causality, preventability and clinical significance classifications. RESULTS: Over 22 weeks of data collection, a total of 11,564 patients were admitted, 2933 met eligibility criteria. Of those eligible, 127 [4.3%, 95% confidence interval (CI) 3.6, 5.0] were judged to have hospital admissions associated with DRPs. Direct costs associated with DRPs identified totalled pounds 100,707. Of the 81 cases assessed for preventability, 46.9% were deemed preventable. CONCLUSIONS: This research has provided information on the nature and characteristics of paediatric DRPs associated with hospital admissions.
Authors: I Martínez-Mir; M García-López; V Palop; J M Ferrer; L Estañ; E Rubio; F J Morales-Olivas Journal: Br J Clin Pharmacol Date: 1996-09 Impact factor: 4.335
Authors: S Major; S Badr; L Bahlawan; G Hassan; T Khogaoghlanian; R Khalil; A Melhem; R Richani; F Younes; J Yeretzian; M Khogali; R Sabra Journal: Clin Pharmacol Ther Date: 1998-10 Impact factor: 6.875
Authors: Asia N Rashed; Antje Neubert; Stephen Tomlin; John Jackman; Hani Alhamdan; Adnan AlShaikh; Ahmed Attar; Mohammed Aseeri; Lynda Wilton; Ian C K Wong Journal: Eur J Clin Pharmacol Date: 2012-05-30 Impact factor: 2.953
Authors: L Lindell-Osuagwu; K Sepponen; S Farooqui; H Kokki; K Hämeen-Anttila; K Vainio Journal: Eur J Clin Pharmacol Date: 2012-10-24 Impact factor: 2.953